發送短信 : Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

 _    _     _____    __   _      ___              
| |  | ||  |  ___|| | || | ||   / _ \\      ___   
| |/\| ||  | ||__   | '--' ||  | / \ ||    /   || 
|  /\  ||  | ||__   | .--. ||  | \_/ ||   | [] || 
|_// \_||  |_____|| |_|| |_||   \___//     \__ || 
`-`   `-`  `-----`  `-`  `-`    `---`       -|_|| 
                                             `-`